🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence

International Journal of Molecular Sciences(2020)10.3390/ijms21020409Source: DataRank Database

Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence is a research paper published in International Journal of Molecular Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 53 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access53 citations

Cite:

Linked data & code

refsnp nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (36 grants)Impact (FWCI 3.27)OA: goldTopics (66)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Josh Bell,Giuseppe Citerio ORCID,J. Claude Hemphill ORCID,W. Taylor Kimberly ORCID,Raj K. Narayan ORCID

Live enrichment

PubMed:31936452 PMC:PMC7013742 OpenAlex:https://openalex.org/W3000556825

National Institute of Neurological Disorders and Stroke

Grant: K23NS101036

National Institute of Neurological Disorders and Stroke

Grant: R01NS060801; R01NS102589; R01NS105633

National Institute of Neurological Disorders and Stroke

Grant: R01NS099209

National Institute of Neurological Disorders and Stroke

Grant: U01NS113443

National Institute of Neurological Disorders and Stroke

Grant: UO1NS106513, R01NS110721, RO1NR018335, U24NS107215, U24NS107136

U.S. Department of Veterans Affairs

Grant: I01BX002889

U.S. Department of Defense

Grant: SCI170199

National Heart, Lung, and Blood Institute

Grant: R01HL082517

American Heart Association

Grant: 7CSA33550004

American Heart Association

Grant: 17CSA33550004

University of Pittsburgh Dean's Faculty Advancement Award

Grant: NA

NINDS NIH HHS

Grant: R01 NS060801

NINDS NIH HHS

Grant: R01 NS102589

NINDS NIH HHS

Grant: R01 NS110721

NCATS NIH HHS

Grant: UL1 TR001863

NINDS NIH HHS

Grant: R01 NS105633

NINR NIH HHS

Grant: R01 NR018335

NINDS NIH HHS

Grant: U01 NS106513

NINDS NIH HHS

Grant: U24 NS107136

NINDS NIH HHS

Grant: U24 NS107215

National Institutes of Health

Grant: 5R01NS060801-02

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel

National Institutes of Health

Grant: 5R01NS105633-04

Fn14, non-canonical NF-kappaB and downstream signaling in neuropathic pain

National Institutes of Health

Grant: 5U24NS107136-03

Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)

National Institutes of Health

Grant: 1I01BX002889-01A2

Gulf War neurotoxicants and acquired cognitive and neuropsychological dysfunction

National Institutes of Health

Grant: 5U24NS107215-07

Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)

National Institutes of Health

Grant: 5R01NR018335-02

The Recovery in Stroke Using PAP (RISE UP) Study

National Institutes of Health

Grant: 1U01NS106513-01A1

Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)

National Institutes of Health

Grant: 5U01NS106513-04

Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)

National Institutes of Health

Grant: 1U24NS107215-01

Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)

National Institutes of Health

Grant: 5R01NR018335-05

The Recovery in Stroke Using PAP (RISE UP) Study

National Institutes of Health

Grant: 5R01NS102589-05

Non-canonical NF-kappaB signaling and Sur1-Trpm4 in traumatic brain injury

National Institutes of Health

Grant: 5R01NS099209-05

Metabolomic predictors of stroke in REGARDS

National Institutes of Health

Grant: 5K23NS101036-03

Translational assessment of sulfonylurea receptor-1 as a biomarker and therapeutic target for cerebral edema in traumatic brain injury

National Institutes of Health

Grant: 5U01NS113443-03

Multicenter preclinical trial of rho-kinase inhibitor fasudil in acute focal cerebral ischemia and reperfusion

National Institutes of Health

Grant: 3R01HL082517-09S2

Sulfonylurea receptor 1 (SUR1) - A novel therapeutic target in ischemic stroke

National Institutes of Health

Grant: 1R01NS110721-01A1

Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imaging

FWCI

3.27

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/21/2/409/pdf?version=1578555226

publisherhttps://www.mdpi.com/1422-0067/21/2/409/pdf?version=1578555226

publisherhttps://www.mdpi.com/1422-0067/21/2/409/pdf

journalhttps://doi.org/10.3390/ijms21020409

repositoryhttps://pubmed.ncbi.nlm.nih.gov/31936452

Fields of Study

Traumatic Brain Injury and Neurovascular DisturbancesCardiac Arrest and ResuscitationHeme Oxygenase-1 and Carbon Monoxide03 medical and health sciences0302 clinical medicine

MeSH Terms

Brain Injuries, TraumaticAnimalsClinical Trials as TopicGlyburideHumansGenetic VariationTRPM Cation ChannelsSulfonylurea Receptors

Keywords

GlibenclamideMedicineSulfonylurea receptorTraumatic brain injurySulfonylureaIschemiaBioinformaticsPharmacologyAnesthesiaInternal medicineEndocrinologyDiabetes mellitusPsychiatryBiologyCerebral edemaGlyburideAstralTbi (Traumatic Brain Injury)Sur1 (Sulfonylurea Receptor 1)Trpm4 (Transient Receptor Potential Melastatin 4)Contusion ExpansionTraumaticPhysical Injury - Accidents and Adverse EffectsTRPM4610TRPM Cation ChannelsReviewTraumatic Brain Injury (TBI)Sulfonylurea ReceptorsMicrobiologyMedicinal and Biomolecular Chemistry616TBIBrain Injuries, TraumaticGeneticsAnimalsHumansTraumatic Head and Spine InjuryClinical Trials as TopicChemical PhysicsSUR1 (Sulfonylurea receptor 1); TRPM4 (transient receptor potential melastatin 4); TBI (traumatic brain injury); cerebral edema; contusion expansion; glibenclamide; glyburide;NeurosciencesGenetic VariationBiological SciencesBrain DisordersGood Health and Well BeingSUR1Brain InjuriesBiochemistry and cell biologyChemical SciencesOther Biological SciencesOther Chemical SciencesASTRAL; Cerebral edema; Contusion expansion; Glibenclamide; Glyburide; SUR1 (Sulfonylurea receptor 1); TBI (traumatic brain injury); TRPM4 (transient receptor potential melastatin 4);

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (7)

Sulfonylurea receptors and mechanism of sulfonylurea action

Experimental and Clinical Endocrinology & Diabetes(2009)

OpenAlex related

10.1055/s-0029-1211414

Tooth Discoloration in Patients With Neonatal Diabetes After Transfer Onto Glibenclamide

Diabetes Care(2009)

OpenAlex related

10.2337/dc09-0280

Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor I. Binding characteristics

Biochimica et Biophysica Acta (BBA) - Biomembranes(1994)

OpenAlex related

10.1016/0005-2736(94)90177-5

Different Amounts of Insulin Secretion Following an Equal Total Decrease of Blood Glucose as an Indication of Possible Extrapancreatic Activities of Different Sulfonylurea Drugs

Hormone and Metabolic Research(1973)

OpenAlex related

10.1055/s-0028-1093992

Early Glibenclamide Treatment in a Clinical Newborn With KCNJ11 Gene Mutation

Diabetes Care(2007)

OpenAlex related

10.2337/dc07-1318

Studies on Insulin Secretion after the Administration of Sulfonylurea in Normal and Diabetic Subjects

Folia Endocrinologica Japonica(1974)

OpenAlex related

10.1507/endocrine1927.50.1_19

Oral Pharmacological Treatment of Neonatal Diabetes

(2023)

OpenAlex related

10.1007/978-3-031-07008-2_8